RNA4RARE Therapeutics Marks First Anniversary and Advances Neurofibromatosis type 1 and 2 mRNA Programs Through a $900,000 Research Project Supported by Génome Québec/Genome Canada

A new collaboration with The Neuro at McGill University aims to generate the preclinical data needed to move RNA4RARE's mRNA approach closer to patients.